|
Dr. Piyali Dasgupta Assistant Professor of Pharmacology, Physiology and Toxicology
Education B.S. (Chemistry), University of Delhi M.S. (Chemistry), Indian Institute of Technology Ph.D. (Cancer Biology), Jawaharlal Nehru University
Research Dr. Dasgupta’s laboratory focuses on the signaling pathways by which components of cigarette smoke, such as nicotine and benzo(a)pyrene (BaP), can function in a receptor-dependent fashion to facilitate the growth and metastasis of lung cancers. Lung cancer is the leading cause of cancer deaths among women. Recent studies indicate that female smokers have an increased risk for developing lung cancer, particularly being at greater risk for adenocarcinoma. Dr. Dasgupta is MU-ADVANCE's Faculty Fellow for the 2009-10 academic year. In addition the the fellowship, she has received funding from the Flight Attendant Medical Research Institute, the Astellas Foundation, and the American Retina Foundation.
Teaching Background Dr. Dasgupta serves as a reviewer for the following journals: Toxicology and Applied Pharmacology Journal, International Journal of Cancer, Journal of Cellular Physiology, Journal of Controlled Release, and the Molecular and Cellular Biochemistry Journal. She is currently a member of The New York Academy of Sciences (NYAS) and The American Association of Cancer Research (AACR). At this year’s Brain Expo, held at Marshall University, Dr. Dasgupta presented an interactive learning station, “Conditioning of the Mind, Pavlov’s Experiment,” to a group of children. The Expo was part of the larger international campaign, “Brain Awareness Week,” geared toward exposing both children and the community to issues about neuroscience and neuroscience research. Contact Info telephone: (304) 696-3612 email: dasgupta@marshall.edu
|
